Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

25. Februar 2019 09:30 ET | Quelle: Biofrontera AG

Biofrontera Honored with Prestigious Silver Stevie(R) Award for Outstanding U.S. Customer Service Department of the Year

Leverkusen, Germany, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the "Company"), an international biopharmaceutical company, today announced that...
11. Februar 2019 10:02 ET | Quelle: Biofrontera AG

Biofrontera implements new Falsified Medicines Directive

Leverkusen, Germany, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, has implemented all...
22. Januar 2019 11:18 ET | Quelle: Biofrontera AG

Biofrontera announces preliminary unaudited sales revenue and updates consolidated net income guidance for the full year 2018

Ad-hoc Release pursuant to Art. 17 MAR Leverkusen, Germany, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ ticker symbol: BFRA, ISIN: DE0006046113), an international biopharmaceutical...
08. Januar 2019 02:02 ET | Quelle: Biofrontera AG

Biofrontera receives FDA approval for upscaling of batch size for Ameluz® production

Leverkusen, Germany, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced that...
27. Dezember 2018 15:31 ET | Quelle: Biofrontera AG

Ruling by the U.S. District Court of Massachussetts

Leverkusen, Germany, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today comments on a...
26. November 2018 13:08 ET | Quelle: Biofrontera AG

Biofrontera to Participate in Two Upcoming Investor Conferences

Leverkusen, Germany, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced its...
16. November 2018 02:20 ET | Quelle: Biofrontera AG

Biofrontera reports earnings results for the third quarter and first nine months of 2018

Leverkusen, Germany, Nov. 16, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...
05. November 2018 06:26 ET | Quelle: Biofrontera AG

Biofrontera Announces Conference Call to Discuss Q3 2018 Financial Results

Leverkusen, Germany, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its...
15. Oktober 2018 04:19 ET | Quelle: Biofrontera AG

Biofrontera to Present at the 4th Annual Dawson James Small Cap Growth Stock Conference

Leverkusen, Germany, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, today announced that Dr. Hermann...
10. Oktober 2018 09:22 ET | Quelle: Biofrontera AG

Biofrontera announces preliminary unaudited sales revenue for the first nine months of 2018 and increases revenue guidance

Leverkusen, Germany, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ ticker symbol: BFRA, ISIN: DE0006046113), an international biopharmaceutical company, today announced preliminary...

Vorherige Seite